Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Invested Capital (2016 - 2024)

Historic Invested Capital for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $87.8 billion.

  • Sanofi's Invested Capital fell 82.35% to $87.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $87.8 billion, marking a year-over-year decrease of 82.35%. This contributed to the annual value of $100.4 billion for FY2024, which is 252.04% up from last year.
  • Per Sanofi's latest filing, its Invested Capital stood at $87.8 billion for Q2 2025, which was down 82.35% from $100.4 billion recorded in Q4 2024.
  • Sanofi's 5-year Invested Capital high stood at $101.7 billion for Q4 2021, and its period low was $5.7 billion during Q2 2021.
  • Over the past 5 years, Sanofi's median Invested Capital value was $88.6 billion (recorded in 2024), while the average stood at $82.4 billion.
  • As far as peak fluctuations go, Sanofi's Invested Capital plummeted by 9223.21% in 2021, and later skyrocketed by 128811.06% in 2022.
  • Quarter analysis of 5 years shows Sanofi's Invested Capital stood at $101.7 billion in 2021, then dropped by 5.73% to $95.9 billion in 2022, then rose by 1.61% to $97.4 billion in 2023, then increased by 3.07% to $100.4 billion in 2024, then dropped by 12.56% to $87.8 billion in 2025.
  • Its last three reported values are $87.8 billion in Q2 2025, $100.4 billion for Q4 2024, and $88.6 billion during Q2 2024.